BioSenic SA
BIOS | BR
Overview
Corporate Details
- ISIN(s):
- BE0970179827 (+1 more)
- LEI:
- 549300HFIIMTOP1DFR76
- Country:
- Belgium
- Address:
- RUE GRANBONPRÉ 11, 1435 MONT-ST-GUIBERT
- Website:
- http://www.biosenic.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of innate immunity, inflammation and organ/function repair. Our expertise is focused on bone cell therapy and the therapeutic use of arsenic trioxide (As2O3). BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for bone and autoimmune and inflammatory diseases. BioSenic has a broad and diverse portfolio of solutions in clinical development in a variety of therapeutic areas targeting markets characterized by significant unmet medical needs and limited innovation.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-10 07:30 |
Legal Proceedings Report
BIOS_PR_20250610_EN.pdf
|
English | 329.1 KB | |
| 2025-06-10 07:30 |
Capital/Financing Update
BIOS_PR_20250610-FR.pdf
|
French | 280.9 KB | |
| 2025-06-09 07:30 |
Capital/Financing Update
BIOS_PR_20250610_EN.pdf
|
English | 329.1 KB | |
| 2025-06-09 07:30 |
Legal Proceedings Report
BIOS_PR_20250610-FR.pdf
|
French | 280.9 KB | |
| 2025-03-31 07:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_March_Denominator_EN.pdf
|
English | 285.4 KB | |
| 2025-03-31 07:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_mars_Denominator_FR.pdf
|
French | 249.4 KB | |
| 2025-03-04 21:00 |
Legal Proceedings Report
BIOS_PR_20250304_EN.pdf
|
English | 275.4 KB | |
| 2025-03-04 21:00 |
Legal Proceedings Report
BIOS_PR_20250304_FR.pdf
|
French | 237.3 KB | |
| 2025-01-27 17:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_January_Denominator_EN.pdf
|
English | 287.5 KB | |
| 2025-01-27 17:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_janvier_Denominator_FR.pdf
|
French | 252.0 KB | |
| 2025-01-23 21:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2024_December_Denominator_EN.pdf
|
English | 288.4 KB | |
| 2025-01-23 21:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2024_décembre_Denominator_FR.pdf
|
French | 251.6 KB | |
| 2025-01-23 21:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025-01-23_Transparency Notification_CGE_EN.pdf
|
English | 283.5 KB | |
| 2025-01-23 21:00 |
Major Shareholding Notification
BIOS_PR_2025-01-23_Transparency Notification_CGE_FR_.pdf
|
French | 249.7 KB | |
| 2025-01-03 00:00 |
Major Shareholding Notification
BIOS_PR_03012025-EN.pdf
|
English | 318.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-16 | Rieger Francois | Board | Sell | 2,500,000 | 25,000.00 EUR |
| 2024-08-06 | Rieger Francois | Board | Sell | 868,653 | 7,186.87 EUR |
| 2024-08-05 | POMI SCHNEITER VERONIQUE | Board | Sell | 534,750 | 4,331.47 EUR |
| 2024-08-02 | POMI SCHNEITER VERONIQUE | Board | Sell | 193,900 | 1,609.37 EUR |
| 2024-08-01 | Rieger Francois | Board | Sell | 1,236,684 | 11,463.87 EUR |
| 2024-08-01 | POMI SCHNEITER VERONIQUE | Board | Sell | 140,003 | 1,246.03 EUR |
| 2024-07-31 | POMI SCHNEITER VERONIQUE | Board | Sell | 503,771 | 4,685.07 EUR |
| 2024-07-30 | POMI SCHNEITER VERONIQUE | Board | Sell | 360,021 | 3,348.20 EUR |
| 2024-07-29 | POMI SCHNEITER VERONIQUE | Board | Sell | 372,893 | 3,430.62 EUR |
| 2024-07-24 | POMI SCHNEITER VERONIQUE | Board | Sell | 2,168,361 | 21,033.10 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |